Advent International buys Suven Pharma for Rs 6,313 crore

Advent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) business, at the same Rs 495 per share from minority shareholders. If fully subscribed to, Advent could end up paying ₹9,589 crore, making it its largest takeover in India yet.

Generated by Feedzy